Heron Net Income from 2010 to 2024

HRTX Stock  USD 2.71  0.06  2.17%   
Heron Therapeuti Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, Heron Therapeuti Net Loss regression line of annual values had significance of  0.01 and arithmetic mean of (120,974,537). View All Fundamentals
 
Net Loss  
First Reported
1989-06-30
Previous Quarter
-25 M
Current Value
-10.7 M
Quarterly Volatility
20.2 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many exotic indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 111. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
This module can also supplement Heron Therapeuti's financial leverage analysis and stock options assessment as well as various Heron Therapeuti Technical models . Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Net Income Growth Pattern

Below is the plot of the Net Income of Heron Therapeuti over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Heron Therapeuti financial statement analysis. It represents the amount of money remaining after all of Heron Therapeuti operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Heron Therapeuti's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (110.56 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Heron Net Income Regression Statistics

Arithmetic Mean(120,974,537)
Coefficient Of Variation(63.10)
Mean Deviation64,533,766
Median(110,559,000)
Standard Deviation76,330,302
Sample Variance5826.3T
Range220.6M
R-Value(0.66)
Mean Square Error3512.7T
R-Squared0.44
Significance0.01
Slope(11,323,744)
Total Sum of Squares81568.4T

Heron Net Income History

2024-105 M
2023-110.6 M
2022-134.5 M
2021-217.7 M
2020-224.4 M
2019-204.7 M
2018-178.8 M

Other Fundumenentals of Heron Therapeuti

Heron Therapeuti Net Income component correlations

About Heron Therapeuti Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Heron Therapeuti income statement, its balance sheet, and the statement of cash flows. Heron Therapeuti investors use historical funamental indicators, such as Heron Therapeuti's Net Income, to determine how well the company is positioned to perform in the future. Although Heron Therapeuti investors may use each financial statement separately, they are all related. The changes in Heron Therapeuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Heron Therapeuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Heron Therapeuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-110.6 M-105 M
Net Loss-163.8 M-172 M
Net Loss-119.7 M-125.7 M
Net Loss(0.80)(0.84)
Net Income Per E B T 0.85  0.92 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heron Therapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heron Therapeuti's short interest history, or implied volatility extrapolated from Heron Therapeuti options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock:
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Heron Stock analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.80)
Revenue Per Share
0.92
Quarterly Revenue Growth
0.14
Return On Assets
(0.25)
Return On Equity
(24.09)
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.